CATHY ARVIDSON: Open Payments
NPI 1134295470 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 10 payments from 9 companies in 2025. Trend: 2023 $361 · 2024 $204 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $165 |
| Novo Nordisk Inc | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Viatris Specialty LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Athena Bioscience, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: SIGNIA, Ozempic, CAPLYTA, YUPELRI, VOQUEZNA, General - Pain Management, BENLYSTA, NEXICLON XR.
Industry payments across ID — which companies pay providers there.
